#mrna-based-vaccin

[ follow ]
#moderna
www.fastcompany.com
8 months ago
Public health

Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs

Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma. [ more ]
www.fastcompany.com
8 months ago
Public health

Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs

Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma. [ more ]
www.fastcompany.com
8 months ago
Public health

Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs

Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma. [ more ]
www.fastcompany.com
8 months ago
Public health

Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs

Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma. [ more ]
moremoderna
www.fastcompany.com
8 months ago
Coronavirus

Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs

Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma. [ more ]
[ Load more ]